Skip to main content
Hansa Biopharma AB (publ) (LON:0RC7)
London flag London · Delayed Price · Currency is GBP · Price in SEK
25.16
+0.28 (1.13%)
At close: May 13, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Antibody-cleaving Enzyme Technology Platform
134.09M
Log In
Log In
Log In
Log In
Upgrade
Antibody-cleaving Enzyme Technology Platform Growth
-13.22%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Europe (excluding Sweden)
106.68M
Log In
Log In
Log In
Log In
Upgrade
Europe (excluding Sweden) Growth
24.66%
Log In
Log In
Log In
Log In
Upgrade
North America
27.42M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
-57.34%
Log In
Log In
Log In
Log In
Upgrade
Sweden
-
Log In
Log In
Log In
Log In
Upgrade
Sweden Growth
-
Log In
Log In
Log In
Log In
Upgrade